Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma

Michael Asger Andersen; Rebecca Valentin; Lene Dissing Sjö; Line Borgwardt; Kjeld Schmiegelow; Mette Klarskov Andersen; Rasmus L Marvig; Christina Westmose Yde; Carsten Utoft Niemann

doi:10.1080/0284186X.2020.1821913

Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma

Michael Asger Andersen, Rebecca Valentin, Lene Dissing Sjö, Line Borgwardt, Kjeld Schmiegelow, Mette Klarskov Andersen, Rasmus L Marvig, Christina Westmose Yde, Carsten Utoft Niemann

Original language	English
Journal	Acta Oncologica
Volume	59
Issue number	12
Pages (from-to)	1547-1551
Number of pages	5
ISSN	0284-186X
DOIs	https://doi.org/10.1080/0284186X.2020.1821913
Publication status	Published - Dec 2020

Access to Document

10.1080/0284186X.2020.1821913

Cite this

Andersen, M. A., Valentin, R., Dissing Sjö, L., Borgwardt, L., Schmiegelow, K., Andersen, M. K., Marvig, R. L., Yde, C. W., & Niemann, C. U. (2020). Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma. Acta Oncologica, 59(12), 1547-1551. https://doi.org/10.1080/0284186X.2020.1821913

Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma. / Andersen, Michael Asger; Valentin, Rebecca; Dissing Sjö, Lene et al.
In: Acta Oncologica, Vol. 59, No. 12, 12.2020, p. 1547-1551.

Research output: Contribution to journal › Letter › peer-review

Andersen, MA, Valentin, R, Dissing Sjö, L , Borgwardt, L , Schmiegelow, K , Andersen, MK , Marvig, RL , Yde, CW & Niemann, CU 2020, 'Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma', Acta Oncologica, vol. 59, no. 12, pp. 1547-1551. https://doi.org/10.1080/0284186X.2020.1821913

Andersen MA, Valentin R, Dissing Sjö L , Borgwardt L , Schmiegelow K , Andersen MK et al. Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma. Acta Oncologica. 2020 Dec;59(12):1547-1551. doi: 10.1080/0284186X.2020.1821913

@article{2e84957c66434eeaa28c6b67e47dca31,

title = "Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma",

author = "Andersen, {Michael Asger} and Rebecca Valentin and {Dissing Sj{\"o}}, Lene and Line Borgwardt and Kjeld Schmiegelow and Andersen, {Mette Klarskov} and Marvig, {Rasmus L} and Yde, {Christina Westmose} and Niemann, {Carsten Utoft}",

year = "2020",

month = dec,

doi = "10.1080/0284186X.2020.1821913",

language = "English",

volume = "59",

pages = "1547--1551",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Informa Healthcare",

number = "12",

}

TY - JOUR

T1 - Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma

AU - Andersen, Michael Asger

AU - Valentin, Rebecca

AU - Dissing Sjö, Lene

AU - Borgwardt, Line

AU - Schmiegelow, Kjeld

AU - Andersen, Mette Klarskov

AU - Marvig, Rasmus L

AU - Yde, Christina Westmose

AU - Niemann, Carsten Utoft

PY - 2020/12

Y1 - 2020/12

UR - http://www.scopus.com/inward/record.url?scp=85091466803&partnerID=8YFLogxK

U2 - 10.1080/0284186X.2020.1821913

DO - 10.1080/0284186X.2020.1821913

M3 - Letter

C2 - 32970500

SN - 0284-186X

VL - 59

SP - 1547

EP - 1551

JO - Acta Oncologica

JF - Acta Oncologica

IS - 12

ER -

Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma

Access to Document

Other files and links

Cite this